Title
Category
Credits
Event date
Cost
Medication Assisted Treatments for Opiates, But What About Stimulants?
  • S.U.D
  • 1.00 AAFP Prescribed
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options.Learning Objective:At the end of this session, learners should be able to:
Telehealth for Substance Use
  • S.U.D
  • 0.50 AAFP Prescribed
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options. Learning Objectives:At the end of this session, participants should be able to:
Pregnancy and Women’s SUD
  • S.U.D
  • Women's Health
  • 0.75 AAFP Prescribed
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options.Learning Objectives:After this course, participants should be able to:
Communication Matters: Motivational Interviewing and Substance Use Disorders
  • S.U.D
  • 0.75 AAFP Prescribed
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options. Learning Objectives:At the end of this session, learners should be able to:
Screening and Identifying Opioid Use and Substance Use Disorders
  • S.U.D
  • 0.50 AAFP Prescribed
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options.Learning Objective:At the end of this session, learners should be able to:
Fundamentals of Adverse Childhood Experiences (ACEs) Screening and Response
  • Trauma-Informed Care
$0.00
CAFP's Family Medicine Initiative on Trauma-Informed Care (FIT) enduring activity consists of three separate accredited sessions designed to introduce clinicians to the concepts of toxic stress and Adverse Childhood Experiences (ACEs) as they relate to trauma-informed care. Session 1 introduces clinicians to the concepts of toxic stress and ACEs as they relate to trauma-informed care. Session 2 presents clinicians with best practices and practical strategies to use when responding to ACEs in their patients. And, Session 3 provides regional and state resources to use with patients.
Increasing Physician Efficiency: Eliminating the WAC
  • Miscellaneous
$0.00
Everyone talks about the barriers caused by the EHR, about hours spent entering data, about time after clinic which could be spent with family. Using what’s she’s learned in her practice, Karen Muchowski will share tips on changes YOU can make as an individual to improve your efficiency, so you can eliminate the Work After Clinic (WAC).Learning Objective:At the end of this session, learners should be able to:
MAT and Complex Patients: Addressing Provider Concerns
  • S.U.D
$0.00
Dr. San Bartolome provides case studies and information about managing care for complex patients with addictions who use more than one substance (polysubstance use).Learning Objectives:At the end of this session, learners should be able to:Identify key safety considerations when treating complex, polysubstance use cases for MAT, andExplain 2 strategies for addressing complicated inductions involving methadone and fentanyl.
Medication Abortion Updates in an Evolving Legal Landscape - 2023 Family Medicine POP!
  • Clinical Forum/POP!
  • Women's Health
$0.00
Learn a streamlined approach for providing medication abortions and miscarriage management. We will discuss how to safely and effectively provide this care in an evolving legal landscape.This session was recorded on August 26, 2023 as part of 2023 Family Medicine POP! Information is current as of that date.Learning Objectives:At the end of this session, learners should be able to:
The Long Haul of Caring for Long COVID in Primary Care Settings - 2023 Family Medicine POP!
  • Clinical Forum/POP!
  • Miscellaneous
$0.00
The COVID-19 Public Health Emergency has ended, but with ten to twenty percent of those affected suffering from some form of Post-COVID Condition, also known as Long COVID, family physicians are left with the uncomfortable legacy of figuring out how to care for this poorly defined chronic symptom complex. There is an urgent need for better understanding of the many manifestations of this condition, its pathophysiology, clinical management, and emerging best practices and symptom-directed treatments.

Pages